---
title: Transforming Emerging Modalities into Business Wins
description: Emerging modalities like cell and gene therapies, digital therapeutics, and microbiome-based treatments are transforming science and business.
image: https://go.frost.com/hubfs/Images/2025/HLS/ABM/EmergingModalities/D01_HLS%20ABM%20Emerging%20Modalities_061025_MK3.jpg
---

![D01_HLS ABM Emerging Modalities_061725_MK](https://go.frost.com/hs-fs/hubfs/Images/2025/HLS/ABM/EmergingModalities/D01_HLS%20ABM%20Emerging%20Modalities_061725_MK.jpg?width=2000&height=400&name=D01_HLS%20ABM%20Emerging%20Modalities_061725_MK.jpg "D01_HLS ABM Emerging Modalities_061725_MK")

*Strategic Intelligence That Fuels Growth Across Emerging Modalities*

Why This Case Study Matters

The biotech and pharma innovation cycle is no longer linear—it’s exponential. Emerging modalities like cell and gene therapies, digital therapeutics, and microbiome-based treatments are transforming science and business. But with opportunity comes uncertainty.

This case study shows how one global pharma leader took control—turning market ambiguity into a repeatable growth engine.

Executive-level Takeaways

- How to operationalize emerging modality foresight across R&D, Regulatory, and Medical Affairs
- The value of a living, strategic intelligence engine in today’s fast-moving therapeutic markets
- Cross-functional alignment tactics that accelerate action and minimize internal friction
- Proven methods for opportunity tracking, regulatory awareness, and competitive intelligence

Outcomes That Matter

- 5 high-value growth opportunities identified
- 3 core business functions strategically aligned
- 2 years of sustained strategic value and internal adoption

### Download the Case Study

What You Will Learn

- What distinguishes future-proof organizations from reactive ones
- How to identify hidden growth potential in niche and fragmented markets
- What it takes to lead—not lag—in modality innovation
- Why regulatory awareness and competitive tracking are now mission-critical

Coming June 23

Don’t miss the recording of our webinar on *“Top 10 Growth Opportunities in Healthcare & Life Sciences,”* featuring expert insights and market trends that will help you drive strategic growth.

### Sign up for a complimentary Growth Pipeline Dialog™

A Growth Pipeline Dialog is a structured discussion with our growth experts providing unparalleled technology intelligence and proven implementation best practices. This discussion will spark innovative thinking and help generate a pipeline of growth opportunities you can leverage to maximize your company’s future growth potential.

Upon completing the dialog session, you will receive a $1,000 honorarium* as a token of our appreciation, which can be used towards the purchase of our products and services on [store.frost.com](https:/store.frost.com?utm_source=hslinks).

[ Talk to our experts today! ](https://insights.frost.com/gpdialog?hsCtaTracking=2540db65-be35-44dd-abb4-f667210b0fde%7C973ed019-8950-4e26-8c86-4b58d2df9b85&hsLang=en)

*$1,000 honorarium is subject to eligibility

![drive-growth-image-scaled-2](https://go.frost.com/hubfs/Imported%20sitepage%20images/drive-growth-image-scaled-2.jpg "drive-growth-image-scaled-2")

**